Free Trial

Evoke (LON:EVOK) Trading Up 16.4% - Time to Buy?

Evoke logo with Consumer Cyclical background

Shares of Evoke plc (LON:EVOK - Get Free Report) traded up 16.4% during trading on Tuesday . The company traded as high as GBX 45.90 ($0.60) and last traded at GBX 44 ($0.58). 21,217,725 shares changed hands during trading, an increase of 646% from the average session volume of 2,844,839 shares. The stock had previously closed at GBX 37.80 ($0.49).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a "buy" rating and set a GBX 140 ($1.83) price objective on shares of Evoke in a report on Monday, December 16th.

Check Out Our Latest Stock Analysis on Evoke

Evoke Stock Performance

The business has a 50 day simple moving average of GBX 62.59 and a 200-day simple moving average of GBX 62.10. The firm has a market cap of £207.38 million, a price-to-earnings ratio of -1.16 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, research analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Jonathan (Jon) Mendelsohn purchased 200,000 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was bought at an average price of GBX 48 ($0.63) per share, for a total transaction of £96,000 ($125,654.45). Also, insider Andrea Gisle Joosen bought 14,572 shares of the stock in a transaction on Tuesday, January 28th. The stock was purchased at an average price of GBX 70 ($0.92) per share, for a total transaction of £10,200.40 ($13,351.31). 27.00% of the stock is owned by corporate insiders.

Evoke Company Profile

(Get Free Report)

Recommended Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines